HCA Healthcare Q1 Results: Cautious Outlook Amidst Medicaid Uncertainties

HCA Healthcares Q1 2026 results met Wall Streets expectations, with revenue up 4.3% to $19.11 billion and adjusted EPS at $7.15. EBITDA missed slightly at $3.8 billion, but margins remained strong at 19.9%. Lower patient volumes due to a mild respiratory season and winter storm were offset by boosts from state Medicaid programs and cost controls. Shares dropped after the report due to volume dips and shifts in payer mix. Management is cautious amid Medicaid uncertainties and health exchange volatility, guiding for a potential $600 million to $900 million EBITDA hit. Theyre investing in AI and expanding their network, with Floridas Medicaid approval and AI savings potentially swinging the year. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f0c48ea138687895